Applied BioCode Akcija

Applied BioCode P/TBV

Applied BioCode (6598.TW) Cena/Materialinė buhalterinė vertė (P/MBV) 2026-08-17 dieną yra 3,84. Praėjusiais metais Cena/Materialinė buhalterinė vertė (P/MBV) buvo 2,82 — pokytis 36,35% (didesnis).

P/TBV

3,84

YoY

36,35%

Paskutinį kartą atnaujinta:

Applied BioCode Cena/Materialinė buhalterinė vertė (P/MBV) yra 2026 3,84 . Applied BioCode Cena/Materialinė buhalterinė vertė (P/MBV) buvo 2025 2,82 . Tai sumažėjo 36,35% didesnis lyginant su praėjusiais metais.
Access this data via the Eulerpool API

Applied BioCode Akcijų analizė

Ką veikia Applied BioCode? Applied BioCode Corp is a California-based company that focuses on the development and marketing of diagnostic instruments and tests. The company was founded in 2004 by an experienced management team and has since developed a number of groundbreaking technologies to improve the diagnosis of diseases such as cancer, infectious diseases, and autoimmune diseases. The business model of Applied BioCode Corp is based on the development of innovative diagnostic instruments and test systems based on proprietary technologies. The company has a strong partnership with a leading manufacturer of diagnostic automation systems, allowing a wide range of tests for various diseases to be offered. Applied BioCode Corp also works closely with leading research and development organizations to leverage the latest insights in the field of diagnostics. One of the divisions of Applied BioCode is molecular diagnostics, which is an essential component of modern medicine. Molecular diagnostics enables the detection of genetic changes and deviations related to diseases. Applied BioCode's technology allows for rapid and precise identification of pathogens in clinical samples such as blood, urine, and tissue samples. Another important area for Applied BioCode is infectious disease diagnostics. The company has developed a range of test systems based on a variety of infectious diseases such as influenza, tuberculosis, and sexually transmitted diseases such as chlamydia and gonorrhea. These tests can be performed individually or as a group to facilitate disease diagnosis and improve treatment. Applied BioCode also offers tests for the detection of oncological markers. These tests are crucial for the early detection of cancer and monitoring the treatment of cancer patients. Applied BioCode's technology enables rapid and precise identification of cancer cells in blood or tissue, which can improve the effectiveness of treatment. Another important product of Applied BioCode is the BioCode Analyzer, an automated diagnostic instrument. The BioCode Analyzer is a high-throughput system capable of performing multiple tests simultaneously. The analyzer is equipped with a disposable chip that allows for quick and easy diagnosis. This makes the BioCode Analyzer a powerful tool for laboratory automation, providing fast and accurate diagnosis for a variety of diseases. Applied BioCode is also dedicated to researching and developing new technologies. The company has an active pipeline of new products and technologies to further improve diagnostic accuracy and the number of feasible tests. Applied BioCode is also developing new applications for its technologies to improve the diagnosis and treatment of diseases in various ways. In summary, Applied BioCode Corp plays an important role in the field of diagnostic technology. The company has developed a wide range of innovative diagnostic tests and instruments that enable diseases to be quickly and accurately detected. With its strong partnership with leading diagnostic automation system manufacturers and research organizations, Applied BioCode will continue to stay at the forefront and improve diagnostic practice. Applied BioCode yra viena populiariausių kompanijų Eulerpool.com.

Dažniausiai užduodami klausimai apie Applied BioCode akciją

Applied BioCode Cena/Materialinė buhalterinė vertė (P/MBV) 2026 m. yra 3,84.

Applied BioCode Cena/Materialinė buhalterinė vertė (P/MBV) pasikeitė nuo 2,82 iki 3,84, tai atitinka 36,35% pokytį. Reikšmė yra didesnis nei praėjusiais metais.

Eulerpool rasite visą Cena/Materialinė buhalterinė vertė (P/MBV) Applied BioCode istorinę raidą nuo 2006 m. – su metinėmis reikšmėmis, grafikais ir išsamiomis analizėmis.

P/MBV lygins akcijos kainą su materialine buhalterine verte vienai akcijai, neįskaičiuojant prestižo ir nematerialaus turto. Tai suteikia konservatyvesnį turto vertę pagrįstą vertinimą.

Norėdami įvertinti Cena/Materialinė buhalterinė vertė (P/MBV), svarbu jį palyginti su toje pačioje pramonėje veikiančiais konkurentais. Eulerpool platformoje galite rasti tiesioginius pramonės palyginimus Cena/Materialinė buhalterinė vertė (P/MBV).

"Geras" skiriasi priklausomai nuo pramonės šakos ir įmonės etapo. Eulerpool platformoje galite palyginti Cena/Materialinė buhalterinė vertė (P/MBV) Applied BioCode su sektoriaus konkurentais ir pramonės vidurkiu, kad įvertintumėte jo patrauklumą.

Access this data via the Eulerpool API

Vertinimas — Applied BioCode

Visi pagrindiniai rodikliai — Applied BioCode